COSCIENS

Serial Number 98915645
641

Registration Progress

Application Filed
Dec 20, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Sep 09, 2025 40 days

Trademark Image

COSCIENS

Basic Information

Serial Number
98915645
Filing Date
December 20, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Jun 9, 2025
Application
Pending
Classes
003 005 030 032

Rights Holder

COSCIENS Biopharma Inc.

03
Address
222 Bay Street, Suite 3000
Toronto, Ontario M5K1E7
CA

Ownership History

COSCIENS Biopharma Inc.

Original Applicant
03
Toronto, Ontario CA

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
40 days remaining
Non-Final Action Mailed
Due Date
September 09, 2025
Extension Available
Until December 09, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

6 events
Date Code Type Description Documents
Jun 9, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 9, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 9, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 7, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 28, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 20, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 003
Toiletry preparations; Class 3 personal care products; animal and pet care products, namely, animal humectant, namely, moisturizers and conditioners, animal shampoo; oat based cosmetic products for animals, namely, animal skin creams and balms; cosmetics; cosmetics, namely, shampoo, anti-irritant creams, moisturizing creams, skin creams, skin balms, oat based cosmetic products, namely, skin moisturizing products in the form of creams, gels and lotions; sunblock and sunscreen lotions, eye shadow and blush powders, lip sticks and balms; avenanthramides and oat beta glucan for use as ingredients in cosmetics;
Class 005
Nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals; Class 5 medical and sanitary preparations; dietetic food and substances adapted for medical or veterinary use; dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing avenanthramides; nutritional supplements, cosmeceuticals, nutraceuticals and pharmaceuticals, containing oat beta glucan; veterinary medicine products, namely, natural (non-antibiotic) anti-microbial preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, shampoo; nutritional additives for animal feed, nutritional supplements, namely oat based supplements; additives to fodder for medical purposes; pharmaceutical preparations in the areas of nutrition and immunology; pharmaceuticals preparation for immunology and inflammation based diseases; avenanthramides and oat beta glucan for use as ingredients in nutritional supplements, cosmeceuticals, nutraceuticals, and pharmaceuticals; pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; synthetic peptides-containing pharmaceutical preparations used for hormonal and tumors treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of carcinoid tumors; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of non-malignant tumors; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia; pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations containing cytotoxic products, conjugated or not, for the treatment of cancer or infectious diseases; pharmaceutical preparations used as a tubulin inhibitor for the treatment of cancer; pharmaceutical preparations based on LHRH antagonists platform for the treatment of cancer, hormonal tumors, or hormonal disorders; pharmaceutical preparations based on bombesin antagonist platform for the treatment of cancer; pharmaceutical preparations based on inhibitors of the Akt pathway for the treatment of cancer or infectious diseases; pharmaceutical preparations based on angiogenesis inhibitors platform for the treatment of cancer; pharmaceutical preparations used to induce apoptosis; pharmaceutical preparations used to stimulate growth hormone secretagogue; vaccines for the treatment of tumors; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, comprising growth hormone secretagogues, ghrelin receptor agonists, ghrelin receptor antagonists, ghrelin mimetics, growth hormone analogues, growth hormone fusion proteins, growth hormone releasing hormone analogues, auto immune modulating proteins, therapeutic antibodies, small molecule kinase inhibitors, phospholipids for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial and fungicidal preparations; pharmaceutical preparations for the treatment of mental health; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic pharmaceutical products, comprising small molecule kinase inhibitors, phospholipids, therapeutic antibodies, natural products; sedativa and pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications
Class 030
Bread; flour and preparations made from cereals; Class 30 food products; oat based food products, namely, oat bran, oat flour, oat starch, oat beta glucan, noodles and medicinal oils;
Class 032
Non-alcoholic beverages; preparations for making non-alcoholic beverage; Class 32 beverage products; beverages, namely, non alcoholic fibre health beverages for human and animal use;

Classification

International Classes
003 005 030 032